UK’s Rising Rebate Threatens Branded Generic And Biosimilar Supply
BGMA Warns Of Market Withdrawals And Calls For Government Strategy For Sector
Warnings over a rising UK rebate that applies to branded generics and biosimilars have gained renewed urgency after some firms indicated plans to cut supply or withdraw from the market altogether, according to local off-patent industry association the BGMA.
